Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Reviews in Medical Virology
|
July 3, 2019
Toll-like receptors as novel therapeutic targets for herpes simplex virus infection
Rana Jahanban-Esfahlan, Khaled Seidi, Maryam Majidinia, et al.
Nature Immunology
|
August 2, 2011
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T Pallotta, Ciriana Orabona, Claudia Volpi, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 12, 2013
Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines
Rossana G Iannitti, Agostinho Carvalho, Cristina Cunha, et al.
Xenotransplantation
|
July 3, 2015
Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy
Giovanni Luca, Francesca Mancuso, Mario Calvitti, et al.
Journal of Medicinal Chemistry
|
March 12, 2020
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor
Desirée Bartolini, Francesca De Franco, Pierangelo Torquato, et al.
Journal of Cellular and Molecular Medicine
|
March 19, 2015
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1
Rita Romani, Irene Pirisinu, Mario Calvitti, et al.
Frontiers in Immunology
|
April 21, 2023
A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation
Massimo R Mannarino, Vanessa Bianconi, Giulia Scalisi, et al.
Nature Communications
|
October 7, 2018
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Amine Meliani, Florence Boisgerault, Romain Hardet, et al.
Nature Medicine
|
April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Luigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment
Sonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Reviews in Medical Virology
|
July 3, 2019
Toll-like receptors as novel therapeutic targets for herpes simplex virus infection
Rana Jahanban-Esfahlan, Khaled Seidi, Maryam Majidinia, et al.
Nature Immunology
|
August 2, 2011
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
Maria T Pallotta, Ciriana Orabona, Claudia Volpi, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 12, 2013
Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines
Rossana G Iannitti, Agostinho Carvalho, Cristina Cunha, et al.
Xenotransplantation
|
July 3, 2015
Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy
Giovanni Luca, Francesca Mancuso, Mario Calvitti, et al.
Journal of Medicinal Chemistry
|
March 12, 2020
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor
Desirée Bartolini, Francesca De Franco, Pierangelo Torquato, et al.
Journal of Cellular and Molecular Medicine
|
March 19, 2015
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1
Rita Romani, Irene Pirisinu, Mario Calvitti, et al.
Frontiers in Immunology
|
April 21, 2023
A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation
Massimo R Mannarino, Vanessa Bianconi, Giulia Scalisi, et al.
Nature Communications
|
October 7, 2018
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Amine Meliani, Florence Boisgerault, Romain Hardet, et al.
Nature Medicine
|
April 11, 2017
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Luigina Romani, Vasilis Oikonomou, Silvia Moretti, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment
Sonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Page
of 15